Abstract
Two [PdN3L]PF6 complexes (L = 2,6-bis(1-ethyl-benzimidazol-2́-yl)pyridine (LBZ) and 4-(2-pyridyl)-2,2′:6′,2′'-terpyridine (LPY)) underwent catalyst-free 1,3-dipolar cycloaddition coupling with phenyl isothiocyanate at the room temperature giving the corresponding tetrazole–thiolato complexes. 1H NMR studies showed that the N1-isomer appeared first in the catalyst-free coupling, then gradually isomerized to the more stable tetrazole–thiolato isomer. The interconversion of N1-isomer into the S-isomer is accompanied by a decrease of the greater steric demand of the 5-membered ring. Tetrazolate complex of LBZ displayed higher antifungal activity (MIC ≤ 0.25 μg/mL) than the chloride analogue (MIC = 0.5–1.0 μg/mL) and the reference drug, Fluconazole (MIC = 0.125–8.0 μg/mL) against Candida albicans and Cryptococcus neoformans. The treated non-cancerous human embryonic kidney cells (HEK293) showed no cytotoxicity and no haemolysis release at the measured concentrations of the chloride complex of LBZ and tetrazolate complex of LPY.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
